US Stock MarketDetailed Quotes

SLP Simulations Plus

Watchlist
  • 31.320
  • +1.280+4.26%
Close Nov 22 16:00 ET
  • 31.317
  • -0.003-0.01%
Post 16:02 ET
628.50MMarket Cap63.92P/E (TTM)

About Simulations Plus Company

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.

Company Profile

SymbolSLP
Company NameSimulations Plus
Listing DateJun 18, 1997
Issue Price5.00
Founded1996
CEOMr. Shawn O’Connor
MarketNASDAQ
Employees247
Fiscal Year Ends08-31
Address42505 10th Street West
CityLancaster
ProvinceCalifornia
CountryUnited States of America
Zip Code93534-7059
Phone1-661-723-7723

Company Executives

  • Name
  • Position
  • Salary
  • Shawn O’Connor
  • Chief Executive Officer
  • 1.94M
  • William Frederick
  • Chief Operating Officer,Chief Financial Officer and Principal Accounting Officer
  • 880.90K
  • Steven Chang
  • President, Quantitative Systems Pharmacology
  • --
  • Murry Alper
  • President, Medical Communications
  • --
  • Jill Fiedler-Kelly, M.S.
  • President, Clinical Pharmacology and Pharmacometric Services
  • 722.10K
  • Dr. Walter S. Woltosz
  • Chairman of the Board
  • 199.99K
  • Jenna Rouse
  • President, Adaptive Learning & Insights
  • --
  • Dr. Sandra Suarez-Sharp
  • President, Regulatory Strategies Center of Excellence
  • --
  • Michael Raymer
  • President, Business Unit
  • --
  • John A. DiBella
  • President, PBPK, Regulatory Strategies and Cheminformatics Solutions
  • 728.14K
  • Dr. Lisa LaVange
  • Independent Director
  • 189.99K
  • Dr. Daniel Weiner
  • Lead Independent Director
  • 199.99K
  • Sharlene Evans
  • Independent Director
  • 187.49K
  • Dr. John K. Paglia, C.F.A.,C.P.A.,PhD
  • Independent Director
  • 199.99K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data